Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Don’t Miss

21 Oct 2021

Impressive Lineup of Industry Experts Speaking at Virtual Summit This Weekend

Summit will bring together over 40 leading experts in the field of psychedelics...

By Microdose

Events

20 Oct 2021

Microdose Announces Red Light Holland as Wonderland Gold Sponsor

Microdose Announces Red Light Holland as Wonderland Gold Sponsor...

By Microdose

Events

20 Oct 2021

Microdose Announces Dimensions Health Centers as Wonderland Gold Sponsor

Microdose Announces Dimensions Health Centers as Wonderland Gold Sponsor...

By Microdose

Events

19 Oct 2021

Microdose Announces Nue Life as Wonderland Gold Sponsor

Microdose Announces NUE....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Events

19 Oct 2021

Microdose Announces Braxia Scientific as Wonderland Gold Sponsor

Microdose Announces Braxia Scientific as Wonderland Gold Sponsor...

By Microdose

Psychedelic Groundbreakers

14 Oct 2021

Psychedelic Groundbreakers: Ketamine StartUp

This week's Psychedelic Groundbreaker is Ketamine StartUp....

By Microdose

Psychedelic Titans

14 Oct 2021

Psychedelic Titans with Lynn Marie Morski of Psychedelic Medicine Association

This week's Psychedelic Titan is Lynn Marie Morski, President of the Psychedelic Medicine Association....

By Microdose

Psychedelic Titans

5 Oct 2021

Psychedelic Titans with Boaz Wachtel of Ibogacine

This week's Psychedelic Titan is Boaz Wachtel, Founder & Executive Chairman for Ibogacine....

By Microdose

Psychedelic Groundbreakers

30 Sep 2021

Psychedelic Groundbreakers: Integration Communications

Integration Communications envisions a world where psychedelics are safely, sustainably, effectively, and ethically integrated into our culture as tools for health, creativity, and human well-being....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.